Literature DB >> 16176497

Functional Assessment in Migraine (FAIM) questionnaire: development of an instrument based upon the WHO's International Classification of Functioning, Disability, and Health.

Dev S Pathak1, Deena J Chisolm, Kathleen A Weis.   

Abstract

OBJECTIVE: The goal of this project was to develop a migraine functional measurement instrument, derived from the World Health Organization International Classification of Impairments, Disabilities, and Handicaps version 2 classification system, which focuses on functional outcomes, and is both reliable and valid.
METHODS: The Functional Assessment in Migraine (FAIM) questionnaire was developed using a multistep approach to ensure the brevity, relevance, reliability, and validity of items. A test set of 71 Mental Functioning and 50 Activity and Participation items was generated and administered to migraineurs in the United States and Germany. A subset of 22 Mental Functioning and 28 Activity and Participation items that rated highly on frequency-weighted importance and showed strong psychometric properties was piloted to determine a final item set and to test reliability and validity.
RESULTS: The final version of the FAIM included nine Mental Functioning items measuring the dimensions of Attention/Thought (5 items) and Perception (4 items), and a list of 28 Activity and Participation items from which respondents chose the five items most relevant to their lifestyle. Construct validity analysis of FAIM dimensions found significant positive correlations with self-reported symptom severity, moderately significant positive correlations with dimensions of the Migraine-Specific Quality of Life questionnaire and no significant correlation with Short Form Health Survey (SF-12) component scores.
CONCLUSION: The FAIM offers physicians a brief and valid method of measuring the impact of migraine on mental functioning and activity and participation as defined by the WHO International Classification of Functioning, Disability, and Health. Additional testing is underway to assess its responsiveness to change.

Entities:  

Mesh:

Year:  2005        PMID: 16176497     DOI: 10.1111/j.1524-4733.2005.00047.x

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  8 in total

Review 1.  [Controlled trials on the efficacy of occupational therapy with elderly. Part I: Research question, search strategy and methodological quality of trials].

Authors:  S Voigt-Radloff; T Schochat; H W Heiss
Journal:  Z Gerontol Geriatr       Date:  2004-12       Impact factor: 1.281

Review 2.  Why HURT? A review of clinical instruments for headache management.

Authors:  Dawn C Buse; C Mark Sollars; Timothy J Steiner; Rigmor H Jensen; Mohammed A Al Jumah; Richard B Lipton
Journal:  Curr Pain Headache Rep       Date:  2012-06

3.  Assessing the impact of headaches and the outcomes of treatment: A systematic review of patient-reported outcome measures (PROMs).

Authors:  Kirstie L Haywood; Tom S Mars; Rachel Potter; Shilpa Patel; Manjit Matharu; Martin Underwood
Journal:  Cephalalgia       Date:  2017-09-18       Impact factor: 6.292

4.  Multidisciplinary recommendations for diagnosis and treatment of foot problems in people with rheumatoid arthritis.

Authors:  Marloes Tenten-Diepenmaat; Marike van der Leeden; Thea P M Vliet Vlieland; Joost Dekker
Journal:  J Foot Ankle Res       Date:  2018-07-04       Impact factor: 2.303

Review 5.  Content Validity of HIT-6 as a Measure of Headache Impact in People With Migraine: A Narrative Review.

Authors:  Carrie R Houts; R J Wirth; James S McGinley; Chad Gwaltney; Eric Kassel; Steven Snapinn; Roger Cady
Journal:  Headache       Date:  2019-12-06       Impact factor: 5.887

6.  Predicting response to physiotherapy treatment for musculoskeletal shoulder pain: protocol for a longitudinal cohort study.

Authors:  Rachel Chester; Lee Shepstone; Jeremy S Lewis; Christina Jerosch-Herold
Journal:  BMC Musculoskelet Disord       Date:  2013-06-21       Impact factor: 2.362

7.  Patient satisfaction with eletriptan in the acute treatment of migraine in primary care.

Authors:  R B Nett; P J Tiseo; M Almas; C R Sikes
Journal:  Int J Clin Pract       Date:  2007-10       Impact factor: 2.503

8.  A universal outcome measure for headache treatments, care-delivery systems and economic analysis.

Authors:  Timothy J Steiner; Mattias Linde; Petra Schnell-Inderst
Journal:  J Headache Pain       Date:  2021-07-01       Impact factor: 7.277

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.